APA (7th ed.) Citation

N, L., Y, Z., W, G., X, Z., D, F., Y, C., . . . E, J. (2026). Evaluation of cyclophosphamide for steroid-refractory hepatic acute graft-vs-host disease after allogeneic hematopoietic stem cell transplantation. Frontiers in immunology, 17, 1678723. https://doi.org/10.3389/fimmu.2026.1678723

Chicago Style (17th ed.) Citation

N, Lu, et al. "Evaluation of Cyclophosphamide for Steroid-refractory Hepatic Acute Graft-vs-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation." Frontiers in Immunology 17 (2026): 1678723. https://doi.org/10.3389/fimmu.2026.1678723.

MLA (9th ed.) Citation

N, Lu, et al. "Evaluation of Cyclophosphamide for Steroid-refractory Hepatic Acute Graft-vs-host Disease After Allogeneic Hematopoietic Stem Cell Transplantation." Frontiers in Immunology, vol. 17, 2026, p. 1678723, https://doi.org/10.3389/fimmu.2026.1678723.